Adicet Bio Inc

Company Profile

Adicet Bio Inc had its IPO on 2018-01-26 under the ticker symbol ACET.

The company operates in the Healthcare sector and Biotechnology industry. Adicet Bio Inc has a staff strength of 86 employees.

Stock update

Shares of Adicet Bio Inc opened at $7.62 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $7.29 - $7.67, and closed at $7.43.

This is a -3.63% slip from the previous day's closing price.

A total volume of 3,544,200 shares were traded at the close of the day’s session.

In the last one week, shares of Adicet Bio Inc have slipped by -0.13%.

Adicet Bio Inc's Key Ratios

Adicet Bio Inc has a market cap of $331.24 million, indicating a price to book ratio of 2.3297 and a price to sales ratio of 13.9986.

In the last 12-months Adicet Bio Inc’s revenue was $30.46 million with a gross profit of $9.73 million and an EBITDA of $-55627000. The EBITDA ratio measures Adicet Bio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Adicet Bio Inc’s operating margin was -188.81% while its return on assets stood at -11.76% with a return of equity of -20.84%.

In Q3, Adicet Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1.1%.

Adicet Bio Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0.82

Its diluted EPS in the last 12-months stands at $-1.44 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0.82. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Adicet Bio Inc’s profitability.

Adicet Bio Inc stock is trading at a EV to sales ratio of 15.7292 and a EV to EBITDA ratio of -8.9083. Its price to sales ratio in the trailing 12-months stood at 13.9986.

Adicet Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$354.30 million

Total Liabilities

$17.22 million

Operating Cash Flow

$-4811000.00

Capital Expenditure

$4.81 million

Dividend Payout Ratio

0%

Adicet Bio Inc ended 2023 with $354.30 million in total assets and $0 in total liabilities. Its intangible assets were valued at $354.30 million while shareholder equity stood at $317.66 million.

Adicet Bio Inc ended 2023 with $0 in deferred long-term liabilities, $17.22 million in other current liabilities, 4000.00 in common stock, $-208240000.00 in retained earnings and $19.46 million in goodwill. Its cash balance stood at $282.68 million and cash and short-term investments were $282.68 million. The company’s total short-term debt was $2,409,000 while long-term debt stood at $0.

Adicet Bio Inc’s total current assets stands at $285.74 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $29000.00 compared to accounts payable of $4.57 million and inventory worth $0.

In 2023, Adicet Bio Inc's operating cash flow was $-4811000.00 while its capital expenditure stood at $4.81 million.

Comparatively, Adicet Bio Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$7.43

52-Week High

$21.87

52-Week Low

$7.41

Analyst Target Price

$27.36

Adicet Bio Inc stock is currently trading at $7.43 per share. It touched a 52-week high of $21.87 and a 52-week low of $21.87. Analysts tracking the stock have a 12-month average target price of $27.36.

Its 50-day moving average was $8.19 and 200-day moving average was $13.43 The short ratio stood at 8.97 indicating a short percent outstanding of 0%.

Around 482.8% of the company’s stock are held by insiders while 10117.9% are held by institutions.